Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

ABL Diagnostics to acquire Vela entities in Asia, US

PRIVATESep 22, 2026about 2 hours ago

Acquiring Company

ABL Diagnostics

Acquired Company

Vela Operations Singapore Pte. Ltd

Grand EstSingaporeBiotechnologyManufacturingBiotechnologyHealth CareMedical DeviceHealth Diagnostics

Description

ABL Diagnostics has signed a non-binding letter of intent to acquire 100% of Vela Operations Singapore Pte. Ltd. and Vela Diagnostics USA Inc. The acquisition aims to extend ABL's commercial presence in Asia-Pacific and the United States. The transaction is subject to various conditions, including due diligence and regulatory approvals. If completed, there will be no change in control of ABL or its parent company.

Company Information

Company

ABL Diagnostics

Location

Grand Est, France

About

ABL Diagnostics is an international company specializing in innovative molecular biology tests. It offers solutions in molecular detection and genotyping services. ABL markets its products globally through sales teams and exclusive distributors. The company is focused on expanding its portfolio in microbiology products.

Fundz sees it the moment ABL Diagnostics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Dimitri
Senior decision-maker at this company
••••••••@••••••••

See Dimitri's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for ABL Diagnostics's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Vela Operations Singapore Pte. Ltd?

Vela Operations Singapore Pte. Ltd was acquired by ABL Diagnostics, based in Grand Est. The deal was reported on September 22, 2026. ABL Diagnostics is an international company specializing in innovative molecular biology tests. It offers solutions in molecular detection and genotyping services. ABL Diagnostics is privately held and operates in Biotechnology.

When did ABL Diagnostics acquire Vela Operations Singapore Pte. Ltd?

ABL Diagnostics's acquisition of Vela Operations Singapore Pte. Ltd was reported on September 22, 2026. ABL Diagnostics has signed a non-binding letter of intent to acquire 100% of Vela Operations Singapore Pte. Ltd. and Vela Diagnostics USA Inc. The acquisition aims to extend ABL's commercial presence in Asia-Pacific and the United States. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Vela Operations Singapore Pte. Ltd do?

Vela Operations Singapore Pte. Ltd. is part of the Vela group, specializing in molecular diagnostics. The company focuses on providing innovative solutions for the diagnostic testing market. It is privately held, operating in Manufacturing, and is based in Singapore.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.